Retrospective analysis shows corticosteroid use increases mortality in critically ill cancer patients with pneumonia, suggesting caution in treatment decisions.
Introduction: The use of corticosteroids is recommended in the management of severe pneumonia in critically ill non-cancer patients; however, their role in oncologic populations remains uncertain. This study aimed to evaluate the association between corticosteroid use and short-term outcomes in critically ill cancer patients with pneumonia using a target trial emulation approach. Methods: We conducted a retrospective target trial emulation using the TriNetX Global Research Network. Adults (18 - 80 years) with cancer and a diagnosis of pneumonia, requiring intensive care interventions (e.g., vasopressors, mechanical ventilation), were included. Patients with asthma, COPD, or COVID-19 were excluded. The intervention group received systemic corticosteroids (dexamethasone, hydrocortisone, methylprednisolone, prednisolone, or prednisone) within 1 month after pneumonia diagnosis; the control group did not. Propensity score matching (1:1) was performed. The primary outcome was 30-day all-cause mortality. Secondary outcomes included mechanical ventilation (MV) for 24–96h, intubation and hemodialysis. Results: After propensity score matching, 25,362 patients were included in each cohort. The use of corticosteroids was associated with a higher 30-day mortality rate (17.8% vs. 13.6%; RR 1.31; 95% CI: 1.26–1.37; HR 1.33; 95% CI: 1.27–1.39; p< 0.001). The need for mechanical ventilation between 24 - 96 hours was also more frequent in the corticosteroid group (2.8% vs. 1.6%; RR 1.73; p< 0.001). Intubation occurred in 6.3% of patients receiving corticosteroids compared to 3.3% in the control group (RR 1.92; p< 0.001). Additionally, hemodialysis was slightly more common among corticosteroid users (0.2% vs. 0.1%; p=0.050). Conclusions: In this large, real-world target trial emulation, corticosteroid use was associated with increased 30-day mortality and greater need for respiratory support among critically ill cancer patients with pneumonia.
No takes yet. Share an insight, caveat, or question.
Papp et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: